Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of cancer patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the U.S. oncology market. QUADRAMET is approved for the treatment of pain in patients whose cancer has spread to the bone, PROSTASCINT is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer, and SOLTAMOX is the first liquid hormonal therapy approved in the U.S. for the treatment of breast cancer in adjuvant and metastatic settings. In early 2007, Cytogen introduced its fourth approved oncology product to the U.S. market, CAPHOSOL®, an advanced electrolyte solution for the treatment of oral mucositis and dry mouth that is approved in the U.S. as a prescription medical device. The Company is also developing CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. Cytogen's product-focused strategy focuses on attaining sustainable growth through clinical, commercial, and strategic initiatives.

Contact Details: 650 College Road East Princeton NJ 08540 United States of America Tel: (800) 833-3533 or (609) 750-8200 Fax: (609) 452-2476 Email: WWW: www.cytogen.com/

Loading...

Recent Publications by Cytogen:
Cytogenetic study of professional rescue rangers of Russian Ministry of Emergencies. Cytogenetic studies in rescue rangers of the Russian Ministry of...	3rd October, 2008	A. M. Nikiforov National Center of Urgent and Radiation Medicine, Ministry	Bull Exp Biol Med. 2007 Oct;144(4):555-8.
Tumoral calcinosis due to GALNT3 C.516-2A >T mutation in a black African family. Familial Tumoral Calcinosis (FTC) is a rare autosomal recessive disorder...	10th September, 2008	Unite de Biologie Humaine, Faculte des Sciences de la Sante, Cotonou,	Genet Couns. 2008;19(2):183-92.
Indium-111 capromab pendetide in the management of recurrent prostate cancer. The provision of accurate prognostic information is a long-standing goal...	28th March, 2008	The George Washington University, Washington, DC, 650 College Road East,	Expert Rev Anticancer Ther. 2008 Feb;8(2):175-81. DOI Direct Link
The emergence of imaging technology in advanced prostate cancer. Rapid advances in imaging technology have whetted our collective appetites...	7th March, 2008	Department of Medical Affairs, Cytogen Corporation, Princeton, NJ, USA.	Can J Urol. 2007 Dec;14 Suppl 1:32-8.
Wolf Hirshhorn syndrome in a case of ring chromosome 4: phenotype and molecular cytogenetic findings. Ring chromosome 4 associates concomitant loss of the telomeric 4p and 4q...	17th October, 2006	Unite de Biologie Humaine, Faculte des Sciences de la Sante, Cotonou,	Genet Couns. 2006;17(1):35-40.
→View more Cytogen research publications.

BioNews Results for Cytogen:
Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market	Nanotechnology News:  Sep 20 2008 9:40PM Matching: cytogen
Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market	Marketwire via Yahoo!:  Sep 18 2008 9:23AM Matching: cytogen
Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market	TMC Net:  Sep 18 2008 12:20PM Matching: cytogen
Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market	Yahoo! Canada:  Sep 18 2008 10:40AM Matching: cytogen
Examine the World Imaging Agents (Contrast Media, Radiopharmaceuticals) Market	Canadian Business Magazine:  Sep 18 2008 10:32AM Matching: cytogen
Promote your company here: BioNewsCast - Press Release Distribution	→View more Cytogen news.

Cytogen Patents:
US Patent No.	Title
7279548	Identification and isolation of novel polypeptides having WW domains and methods of using same
5527885	Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
5495042	Non-alkaline purification of aminophosphonic acids
5449761	Metal-binding targeted polypeptide constructs
5326856	Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
→View more Cytogen patents.

Cytogen (CYTO) Financial information Links from Barchart
CYTO Quote from from Barchart.com
CYTO Chart from from Barchart.com
CYTO Profile from from Barchart.com
CYTO Opinion from from Barchart.com
→View more Cytogen finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 242 times since April 2007, the link to the organisation's website has been followed 40 times

Recent Search Terms used to find this page: cytogen.com | cytogen | www.Cytogen.com | CYTOGEN | cytogen | sm-153 | EUSA Quadramet | .

Search for more companies in Princeton

Search for more companies in NJ

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cytogen